To test the potential confounders that influence the genetic effect on BMD, variables including gender, BMI, T3, alkaline phosphatase, estradiol, and prolactin, which significantly differed between schizophrenia patients and controls, were adjusted in the analysis of covariance. This evidence concerns the gene PRL and schizophrenia.